|
1.
|
Matsuda T, Marugame T, Kamo K, et al:
Cancer incidence and incidence rates in Japan in 2006: Based on
data from 15 population-based cancer registries in the monitoring
of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol.
42:139–147. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Kyo S: Endometrial cancer stem cells: Are
they a possible therapeutic target? Curr Obstet Gynecol Rep.
2:1–10. 2013. View Article : Google Scholar
|
|
3.
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour-initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q and
Hjelmeland AB: Glioma stem cells promote radioresistance by
preferential activation of the DNA damage response. Nature.
444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Gu G, Yuan J, Wills M and Kasper S:
Prostate cancer cells with stem cell characteristics reconstitute
the original human tumor in vivo. Cancer Res. 67:4807–4815. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Miki J, Furusato B, Li H, et al:
Identification of putative stem cell markers, CD133 and CXCR4, in
hTERT-immortalized primary nonmalignant and malignant tumor-derived
human prostate epithelial cell lines and in prostate cancer
specimens. Cancer Res. 67:3153–3161. 2007. View Article : Google Scholar
|
|
8.
|
Eramo A, Lotti F, Sette G, et al:
Identification and expansion of the tumorigenic lung cancer stem
cell population. Cell Death Differ. 15:504–514. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Hermann PC, Huber SL, Herrler T, et al:
Distinct populations of cancer stem cells determine tumor growth
and metastatic activity in human pancreatic cancer. Cell Stem Cell.
1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
O’Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110.
2007.PubMed/NCBI
|
|
11.
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M and Peschle C: Identification and expansion of
human colon cancer - initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Monzani E, Facchetti F, Galmozzi E, et al:
Melanoma contains CD133 and ABCG2 positive cells with enhanced
tumourigenic potential. Eur J Cancer. 43:935–946. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Rutella S, Bonanno G, Procoli A, et al:
Cells with characteristics of cancer stem/progenitor cells express
the CD133 antigen in human endometrial tumors. Clin Cancer Res.
15:4299–4311. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Nakamura M, Kyo S, Zhang B, et al:
Prognostic impact of CD133 expression as a tumor-initiating cell
marker in endometrial cancer. Hum Pathol. 41:1516–1529. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Nakamura M, Bodily JM, Beglin M, Kyo S,
Inoue M and Laimins LA: Hypoxia-specific stabilization of
HIF-1alpha by human papillomaviruses. Virology. 387:442–448. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Mizumoto Y, Kyo S, Mori N, et al:
Activation of ERK1/2 occurs independently of KRAS or BRAF status in
endometrial cancer and is associated with favorable prognosis.
Cancer Sci. 98:652–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Mizumoto Y, Kyo S, Ohno S, et al: Creation
of tumorigenic human endometrial epithelial cells with intact
chromosomes by introducing defined genetic elements. Oncogene.
25:5673–5682. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kato K, Takao T, Kuboyama A, et al:
Endometrial cancer side-population cells show prominent migration
and have a potential to differentiate into the mesenchymal cell
lineage. Am J Pathol. 176:381–392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Maeda S, Shinchi H, Kurahara H, et al:
CD133 expression is correlated with lymph node metastasis and
vascular endothelial growth factor-C expression in pancreatic
cancer. Br J Cancer. 98:1389–1397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Kojima M, Ishii G, Atsumi N, Fujii S,
Saito N and Ochiai A: Immunohistochemical detection of CD133
expression in colorectal cancer: a clinicopathological study.
Cancer Sci. 99:1578–1583. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Ma S, Lee TK, Zheng BJ, Chan KW and Guan
XY: CD133+ HCC cancer stem cells confer chemoresistance
by preferential expression of the Akt/PKB survival pathway.
Oncogene. 27:1749–1758. 2008.
|
|
23.
|
Kim M, Turnquist H, Jackson J, et al: The
multidrug resistance transporter ABCG2 (breast cancer resistance
protein 1) effluxes Hoechst 33342 and is overexpressed in
hematopoietic stem cells. Clin Cancer Res. 8:22–28. 2002.PubMed/NCBI
|
|
24.
|
Doyle LA and Ross DD: Multidrug resistance
mediated by the breast cancer resistance protein BCRP (ABCG2).
Oncogene. 22:7340–7358. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Chiba T, Kita K, Zheng YW, et al: Side
population purified from hepatocellular carcinoma cells harbors
cancer stem cell-like properties. Hepatology. 44:240–251. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Ho MM, Ng AV, Lam S and Hung JY: Side
population in human lung cancer cell lines and tumors is enriched
with stem-like cancer cells. Cancer Res. 67:4827–4833. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Szotek PP, Pieretti-Vanmarcke R, Masiakos
PT, et al: Ovarian cancer side population defines cells with stem
cell-like characteristics and Mullerian Inhibiting Substance
responsiveness. Proc Natl Acad Sci USA. 103:11154–11159. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Christgen M, Ballmaier M, Bruchhardt H,
von Wasielewski R, Kreipe H and Lehmann U: Identification of a
distinct side population of cancer cells in the Cal-51 human breast
carcinoma cell line. Mol Cell Biochem. 306:201–212. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Wang YH, Li F, Luo B, et al: A side
population of cells from a human pancreatic carcinoma cell line
harbors cancer stem cell characteristics. Neoplasma. 56:371–378.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Annabi B, Rojas-Sutterlin S, Laflamme C,
et al: Tumor environment dictates medulloblastoma cancer stem cell
expression and invasive phenotype. Mol Cancer Res. 6:907–916. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Kohga K, Tatsumi T, Takehara T, et al:
Expression of CD133 confers malignant potential by regulating
metalloproteinases in human hepatocellular carcinoma. J Hepatol.
52:872–879. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Kabashima A, Higuchi H, Takaishi H, et al:
Side population of pancreatic cancer cells predominates in
TGF-beta-mediated epithelial to mesenchymal transition and
invasion. Int J Cancer. 124:2771–2279. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Armstrong AJ, Marengo MS, Oltean S, et al:
Circulating tumor cells from patients with advanced prostate and
breast cancer display both epithelial and mesenchymal markers. Mol
Cancer Res. 9:997–1007. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Oda K, Arakawa H, Tanaka T, et al:
p53AIP1, a potential mediator of p53-dependent apoptosis, and its
regulation by Ser-46-phosphorylated p53. Cell. 102:849–862. 2000.
View Article : Google Scholar : PubMed/NCBI
|
